NCT05463549

Brief Summary

The effect of exposure to an informative video about amniocentesis before the procedure on maternal anxiety

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 8, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 27, 2022

Completed
4 months until next milestone

First Posted

Study publicly available on registry

July 19, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
Last Updated

March 14, 2023

Status Verified

March 1, 2023

Enrollment Period

9 months

First QC Date

March 27, 2022

Last Update Submit

March 13, 2023

Conditions

Keywords

explanatory videoanxiety reductionamniocentesispregnancy

Outcome Measures

Primary Outcomes (1)

  • Assessment of change in anxiety levels between before and after undergoing the amniocentesis

    Women recruited to the study will answer the Spielberger's state-trait anxiety inventory questionnaire- a validated questionnaire for assessing anxiety which includes 20 statements expressing different states of anxiety. The patients will be asked to rate to what extent they currently relate to the statement written on a scale of 1 to 4 (1- does not agree at all and 4- strongly agrees). The final score in each questionnaire is obtained by summing the scores of each statement, while the scores of positive statements reflecting anxiety-free behavior will be reversely summed. Higher scores indicate higher level of anxiety.

    Each patient will answer the STAI questionnaire twice - within 2 hours before the operation and watching the video (S1) and within 30 minutes after performing amniocentesis (S2) to assess the change in anxiety levels before and after the operation

Secondary Outcomes (1)

  • Intensity of pain, discomfort, satisfaction with the video and satisfaction in general

    The questionnaire will be filled within 30 minutes after performing amniocentesis

Study Arms (2)

Informative video

EXPERIMENTAL

The research group will be exposed to an informative instructional film before the procedure.

Other: Informative video

No video

NO INTERVENTION

The control group will undergo amniocentesis with information given as accepted by standard-of-care.

Interventions

An informative instructional film regarding the amniocentesis procedure including answers to frequently asked questions.

Informative video

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women who come for amniocentesis in the Edith Wolfson Medical Center
  • Women who sign a consent form to enroll to the study.

You may not qualify if:

  • Women under 18 years of age.
  • Women who do not speak Hebrew

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Edith Wolfson Medical Center

Holon, 5822012, Israel

Location

Related Publications (1)

  • Marom O, Weiner E, Gindes L, Mor L, Gury M, Toledano E, Alon AS, Miremberg H, Shalev J, Levy M. The effect of watching an informational video prior amniocentesis on maternal anxiety: a randomized controlled trail. Arch Gynecol Obstet. 2024 Aug;310(2):1001-1008. doi: 10.1007/s00404-023-07288-y. Epub 2023 Dec 7.

Study Officials

  • Or Marom, Dr

    Edith Wolfson Medical center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Data regarding maternal characteristics, anxiety and pain levels as reported by the patients via the questioners will be stored according to random serial numbers without intervention type. The investigator handling the statistical analysis will be unaware of the patient's exposure.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Women assigned to undergo amniocentesis during the trail time-period will be invited to participate in the study and will be signed a consent form.The randomization will be based on different days for each intervention - a day specified to women comprising of the research group while the following clinic day will be dedicated to women from the control group. The study group will watch an informative video while waiting for amniocentesis, and the control group will not watch the video while waiting.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 27, 2022

First Posted

July 19, 2022

Study Start

February 8, 2022

Primary Completion

October 30, 2022

Study Completion

December 30, 2022

Last Updated

March 14, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will share

Unidentified patient data will be shared between researchers for statistical analysis, other unidentified data will be published.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Within the first 5 years from publication.
Access Criteria
Researches in need of data will request permission from study organizers by mail including data needed, purpose of data sharing and data protection steps.

Locations